These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 33960640)
1. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53. Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN. Ramírez-Moya J; Wert-Lamas L; Santisteban P Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884 [TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway. Zhu B; Wei Y Cancer Med; 2020 Jan; 9(2):783-796. PubMed ID: 31957323 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
5. Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway. Wang H; Liu YC; Zhu CY; Yan F; Wang MZ; Chen XS; Wang XK; Pang BX; Li YH; Liu DH; Gao CJ; Liu SJ; Dou LP J Exp Clin Cancer Res; 2020 Dec; 39(1):278. PubMed ID: 33298132 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway. Miao Y; Zheng W; Li N; Su Z; Zhao L; Zhou H; Jia L Sci Rep; 2017 Feb; 7():41942. PubMed ID: 28165066 [TBL] [Abstract][Full Text] [Related]
7. A biochemical assessment of apoptosis-inducing impact of Salinomycin in combination with ciprofloxacin on human leukemia KG1-a stem-like cells in the presence and absence of insulin. Alhajamee M; Khalaj-Kondori M; Babaei E; Mahdavi M Mol Biol Rep; 2024 Jul; 51(1):807. PubMed ID: 39002036 [TBL] [Abstract][Full Text] [Related]
8. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN. Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796 [TBL] [Abstract][Full Text] [Related]
9. Decreasing of serine/threonine kinase 39 has tumour inhibiting effects on acute myeloid leukaemia by impacting the PI3K/AKT and Wnt/β-catenin signalling cascades. Li C; Xin H; Hao J; Miao Y Toxicol Appl Pharmacol; 2024 Aug; 489():116982. PubMed ID: 38821216 [TBL] [Abstract][Full Text] [Related]
10. PTEN's regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia. Zhiyong C; Wentong L; Xiaoyang Y; Ling P Med Oncol; 2012 Jun; 29(2):1084-92. PubMed ID: 21360018 [TBL] [Abstract][Full Text] [Related]
11. SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN/PI3K/AKT pathway in Burkitt lymphoma. Zhang R; Zhu H; Yuan Y; Wang Y; Tian Z Oncol Rep; 2020 Nov; 44(5):2021-2030. PubMed ID: 33000212 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN. Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551 [TBL] [Abstract][Full Text] [Related]
13. Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells. Marty B; Maire V; Gravier E; Rigaill G; Vincent-Salomon A; Kappler M; Lebigot I; Djelti F; Tourdès A; Gestraud P; Hupé P; Barillot E; Cruzalegui F; Tucker GC; Stern MH; Thiery JP; Hickman JA; Dubois T Breast Cancer Res; 2008; 10(6):R101. PubMed ID: 19055754 [TBL] [Abstract][Full Text] [Related]
14. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways. Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101 [TBL] [Abstract][Full Text] [Related]
15. The Effect of Zbxz23ir-21 NANO(nanomaterials) Delivery Vector on Apoptosis and PTEN(phosphatase and tensin homolog deleted on chromosome ten)/PI3K(Intracellular phosphatidylinositol kinase)/AKT(related to the A and C kinase) in Children with CHOLESTEATOMA in Middle Ear. Zheng H; Wang W; Li S; Han L Bioengineered; 2021 Dec; 12(1):8809-8821. PubMed ID: 34696703 [TBL] [Abstract][Full Text] [Related]
16. ROS play an important role in ATPR inducing differentiation and inhibiting proliferation of leukemia cells by regulating the PTEN/PI3K/AKT signaling pathway. Feng Y; Hua X; Niu R; Du Y; Shi C; Zhou R; Chen FH Biol Res; 2019 May; 52(1):26. PubMed ID: 31053167 [TBL] [Abstract][Full Text] [Related]
17. miR‑494‑3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway. Zhu L; Wang X; Wang T; Zhu W; Zhou X Mol Med Rep; 2019 Jan; 19(1):581-588. PubMed ID: 30431102 [TBL] [Abstract][Full Text] [Related]
18. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer. Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308 [TBL] [Abstract][Full Text] [Related]
19. FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia. Long J; Jia MY; Fang WY; Chen XJ; Mu LL; Wang ZY; Shen Y; Xiang RF; Wang LN; Wang L; Jiang CH; Jiang JL; Zhang WJ; Sun YD; Chang L; Gao WH; Wang Y; Li JM; Hong DL; Liang AB; Hu J Blood; 2020 Apr; 135(17):1472-1483. PubMed ID: 32315388 [TBL] [Abstract][Full Text] [Related]
20. SAMHD1 modulates in vitro proliferation of acute myeloid leukemia-derived THP-1 cells through the PI3K-Akt-p27 axis. Kodigepalli KM; Bonifati S; Tirumuru N; Wu L Cell Cycle; 2018; 17(9):1124-1137. PubMed ID: 29911928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]